Jefferies Global Healthcare Conference
November 16–19, 2026 · London
Laxxon Medical
Press releases and publications from Laxxon Medical.
Laxxon Medical Corp. (“Laxxon Medical” or the “Company”), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs) technology, today announced that members of its senior management team will hold one-on-one investor meetings at the Jefferies Global Healthcare Conference, taking place November 16–19, 2026, in London, United Kingdom.
Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the publication of a new study in the Journal Pharmaceutics (MDPI) that highlights the effectiveness of its proprietary carbidopa/levodopa formulations (LXM.5) for the treatment of Parkinson's disease.
Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the Jefferies Healthcare Conference, two of the world’s premier partnering events for the Life Sciences industry.
Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, today announced that management is participating in the 27th Annual Needham Growth Conference on January 9-17th, 2024.
Laxxon Medical, a leading 3D screen printing platform technology company, announced today its participation in the World Orphan Drug Congress USA 2024, taking place April 23-25, 2024 in Boston, Massachusetts.
Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, announced today their participation as a private company in the 23rd Annual Needham Virtual Healthcare Conference on April 8-11, 2024.
Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their participation in the BIO CEO & Investor Conference taking place at the New York Marriott Marquis on February 6-9, 2023.
Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.
Laxxon Medical Corp., a U.S.-based pharma-technology company pioneering 3D screen printed pharmaceuticals, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent 11,419,824 B2 for the controlled administration of one or more active pharmaceutical ingredients within a drug delivery system via oral dosage forms.
Never before has the pharmaceutical industry faced such a transformative manufacturing technology.
Laxxon Medical Corporation announced today that management would conduct one-on-one meetings at the 24th Annual Needham Growth Conference, which will be held virtually from Jan 10-14, 2022.
November 16–19, 2026 · London
January 11–14, 2027 · San Francisco